Shanade Dunn

Shanade Dunn

Auto-generated profile, based on publicly available information

Shanade Dunn

AstraZeneca 1 Small Molecule Bioscience, Oncology Targeted Discovery, Oncology R&D Cambridge, United Kingdom

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2026
Verified
Other
Open access
VCValentina Cutano
Valentina Cutano
SDShanade Dunn
Shanade Dunn
SPSungmi Park-Chouinard
Sungmi Park-Chouinard
EWEleanor M. Wigmore
Eleanor M. Wigmore
QWQing Wu
Qing Wu
SBSimon T. Barry
Simon T. Barry
List of names and affiliations for individuals associated with the Functional Gemonics Centre FGC.




2 October 2026
Verified
Other
Open access
PDF file
VCValentina Cutano
Valentina Cutano
SDShanade Dunn
Shanade Dunn
SPSungmi Park-Chouinard
Sungmi Park-Chouinard
EWEleanor M. Wigmore
Eleanor M. Wigmore
QWQing Wu
Qing Wu
SBSimon T. Barry
Simon T. Barry
Effects on pathway biomarker responses following treatment of KDM5C and KAT6A KO cells with capivasertib and fulvestrant and the combination.

2 October 2026
Verified
Other
Open access
PDF file
VCValentina Cutano
Valentina Cutano
SDShanade Dunn
Shanade Dunn
SPSungmi Park-Chouinard
Sungmi Park-Chouinard
EWEleanor M. Wigmore
Eleanor M. Wigmore
QWQing Wu
Qing Wu
SBSimon T. Barry
Simon T. Barry
KDM5 and KAT6A/Bi sensitize ER+BC cells to AKT inhibition.